dr gulick infectious disease
IAPAC sessions 2001, July 18-19, 2001 - Chicago. Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. 28, 2023, Ruben Castaneda and Angela HauptFeb. McGowan, I.,Wilkin, T.,Landovitz, R. J.,Wu, C.,Chen, Y.,Marzinke, M. A.,Hendrix, C. W.,Richardson, P.,Eshleman, S. H.,Andrade, A.,Chege, W.,Anderson, P. L.,McCauley, M.,Farley, J.,Mayer, K. H.,Anton, P.,Brand, R. M.,Cranston, R. D.,Gulick, R. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies, Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta, Radwa Sharaf, Wendy Hartogensis, Jeffrey M. Jacobson, Elizabeth Connick, Paul A. Volberding, Daniel J. Skiest, David J. Margolis, Michael C. Sneller, Susan J. The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM. Dr. Roy Gulick MD Infectious Disease General Infectious Disease New York, NY New York-Presbyterian Hospital-Columbia and Cornell Male 21+ Yrs Experience English Accepting New Patients. Amesika N. Nyaku, Lu Zheng, Roy M. Gulick, Maxine Olefsky, Baiba Berzins, Carole L. Wallis, Catherine Godfrey, Paul E. Sax, Edward P. Acosta, David W. Haas, Kimberly Y. Smith, Beverly E. Sha, Cornelius N Van Dam, Babafemi Taiwo, Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions, K. Rivet Amico, Catalina Ramirez, Margaret R Caplan, Brooke E. E. Montgomery, Jennifer M. Stewart, Sally Hodder, Shobha Swaminathan, Jing Wang, Noshima Y Darden-Tabb, Marybeth McCauley, Kenneth H. Mayer, Timothy J. Wilkin, Raphael J. Landovitz, Roy M. Gulick, Adaora A. Adimora, Hptn, A Study Team. Antiretroviral therapy: when and what to start-- an American perspective. Education & Training He received training in two specialties: Infectious Disease at the Cleveland Clinic Foundation and Medical Oncology at Roswell Park Memorial Institute. Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305. Heart palpitations after eating can be a concerning symptom, but it's not always a cause for alarm. Dr. Gulick's office is located at Roy M. Gulick, Christina M. Lalama, Heather J. Ribaudo, Cecilia M. Shikuma, Bruce R. Schackman, Jeffrey T. Schouten, Kathleen Squires, Susan L. Koletar, Christopher D. Pilcher, Richard C. Reichman, Karin L. Klingman, Daniel R. Kuritzkes. Please verify your coverage with the provider's office directly when scheduling an appointment. The Seventh Conference on Retroviruses and Opportunistic Infections. Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-nave HIV-1-infected patients. Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-nave HIV-1-infected patients, Murphy RL, da Silva BA, Hicks CB, Eron JJ, Gulick RM, Thompson MA, McMillan F, King MS, Hanna GJ, Brun SC. Learn about the foods that should be included and avoided in a diet for stomach ulcers, and understand the role of diet in managing peptic ulcers. But, when it comes to shigella, the CDC alert encourages doctors to "make sure that their laboratory is doing the old-fashioned culture," which can assess the strain's susceptibility to particular antibiotics, Gulick explains. Safia S Kuriakose, Kanal Singh, Alice K. Pau, Eric S. Daar, Rajesh T. Gandhi, Pablo Tebas, Laura Evans, Roy M. Gulick, H. Clifford Lane, Henry Masur, Judith A. Aberg, Adaora A. Adimora, Jason V. Baker, Lisa Baumann Kreuziger, Roger Bedimo, Pamela S. Belperio, Stephen V. Cantrill, Craig M. Coopersmith, Susan L Davis, Amy L. Dzierba, John J. Gallagher, David V. Glidden, Birgit Grund, Erica J. Hardy, Carl Hinkson, Brenna L. Hughes, Steven T. Johnson, Marla J. Keller, Arthur Y. Kim, Jeffrey L. Lennox, Mitchell M. Levy, Jonathan Z. Li, Greg S. Martin, Susanna Naggie, Andrew T. Pavia, Nitin Seam, Steven Q. Simpson, Susan Swindells, Phyllis C. Tien, Alpana Waghmare, Kevin C. Wilson, Jinoos Yazdany, Philip Zachariah, Danielle Campbell, Carly Harrison, Timothy Burgess, Joseph Francis, Virginia Sheikh, Timothy M. Uyeki, Robert L. Walker. He is board certified in internal medicine and infectious diseases. Previously, researchers and public health agencies have warned about drug-resistant gonorrhea and urinary tract infections, Sobhanie says, adding that antibiotic resistance is the kind of thing "that keeps infectious disease physicians up at night.". Heather J. Ribaudo, Daniel R. Kuritzkes, Roy M. Gulick. HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug, Opass Putcharoen, Sun Hee Lee, Timothy J. Henrich, Zixin Hu, Jakapat Vanichanan, Eoin Coakley, Wayne Greaves, Roy M. Gulick, Daniel R. Kuritzkes, Athe M. N. Tsibris, CCR5 antagonism in HIV infection: Current concepts and future opportunities, Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development, Bethany L. Morris, Callie A. Scott, Timothy J. Wilkin, Paul E. Sax, Roy M. Gulick, Kenneth A. Freedberg, Bruce R. Schackman, Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: Results from the AIDS Clinical Trials Group Study A5095, Li L, Eron JJ, Ribaudo H, Gulick RM, Johnson BA, Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants, Holzinger ER, Grady B, Ritchie MD, Ribaudo HJ, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford DB, Daar ES, McLaren P, Haas DW, Next-generation oral preexposure prophlaxis: beyond tenofovir, HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that correct in the presence of drug, Putcharoen O, Lee SH, Henrich T, Hu Z, Vanichanan J, Coakley E, Greaves W, Gulick R, Kuritzkes D, Tsibris A, Morris BL, Scott CA, Wilkin TJ, Sax PE, Gulick RM, Freedberg KA, Schackman BR, Differential use of CCR5 by HIV-1 clinical isolates resistant to small molecule CCR5 antagonists, Henrich TJ, Lewine NRP, Lee S-H, Rao SSP, Berro R, Gulick RM, Moore JP, Tsibris AMN, Kuritzkes DR, Novel clinical trials designs for the development of new antiretroviral agents, Mani N, Murray J, Gulick RM, Josephson F, Miller V, Miele P, Strobos J, Struble K, Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures, Tsibris AM, Hu Z, Paredes R, Leopold KE, Putcharoen O, Schure A, Mazur N, Coakley E, Su Z, Gulick RM, Kuritzkes DR, Charles M, Leger PD, Severe P, Guiteau C, Apollon A, Gulick RM, Johnson WD, Pape JW, Fitzgerald DW, A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4+ T-cell recovery despite sustained virologic suppression: ACTG A5256, Wilkin TJ, Lalama CM, McKinnon J, Gandhi RT, Lin N, Landay A, Ribaudo H, Fox L, Currier JS, Mellors JW, Gulick R, Tenorio AR. Ian McGowan, Timothy J. Wilkin, Raphael J. Landovitz, Chunyuan Wu, Ying Q. Chen, Mark A. Marzinke, Craig W. Hendrix, Paul G. Richardson, Susan H. Eshleman, Adriana Andrade, Wairimu Chege, Peter L. Anderson, Marybeth McCauley, Jason E. Farley, Kenneth H. Mayer, Peter A. Anton, Rhonda M. Brand, Ross D. Cranston, Roy M. Gulick. Learn about Medicare Special Needs Plans (SNPs) and how they can provide targeted and enhanced coverage for individuals with specific health needs. W. David Hardy, Roy M. Gulick, Howard Mayer, Gerd Ftkenheuer, Mark T. Nelson, Jayvant Heera, Natasa Rajicic, James Goodrich, The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, Paul J. McLaren, Amalio Telenti, de Bakker Pi, Bruce D. Walker, Stephan Ripke, Chanson J. Brumme, Sara L. Pulit, Mary Carrington, Carl M. Kadie, Jonathan M. Carlson, David E. Heckerman, Graham Rr, Robert M. Plenge, Steven G. Deeks, Gianniny L, Gabriel Crawford, Jean C. Sullivan, Elena Gonzalez, Davies L, Amy L. Camargo, Jamie Moore, Beattie N, Soumi Gupta, Crenshaw A, N P Burtt, Candace Guiducci, Namrata Gupta, Gao X, Qi Y, Yuko Yuki, Alicja Piechocka-Trocha, Emily Cutrell, Rachel Rosenberg, Kristin Moss, Lemay P, Jacqueline G. O'Leary, Schaefer T, Verma P, I Tth, Brian L. Block, Brett Baker, Alissa C. Rothchild, Lian J, Jacqueline Proudfoot, Donna Marie Alvino, Seanna Vine, Marylyn M. Addo, Todd M. Allen, Marcus Altfeld, Matthew R. Henn, Le Gall S, Hendrik Streeck, David W. Haas, Daniel R. Kuritzkes, Gregory K. Robbins, Robert W. Shafer, Roy M. Gulick, Cecilia M. Shikuma, Richard Haubrich, Sharon A. Riddler, Paul E. Sax, Eric S. Daar, Heather J. Ribaudo, Brian K. Agan, Agarwal S, Ryan Ahern, Allen Bl, Altidor S, Altschuler El, Ambardar S, Kathryn Anastos, Brenna L. Anderson, Anderson, Andrady U, Antoniskis D, David R. Bangsberg, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Nesli Basgoz, Suzane Bazner, Nicholas Bellos, Benson Am, Judith Berger, Bernard Nf, Bernard Am, Christopher E. Birch, Bodner Sj, Robert K. Bolan, Boudreaux Et, Meg Bradley, Braun Jf, Brndjar Je, Stephen J. See all conditions on Dr. Gulick's. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. He is affiliated with Sparrow Hospital. Roy M. Gulick, Timothy J. Wilkin, Ying Q. Chen, Raphael J. Landovitz, K. Rivet Amico, Alicia M. Young, Paul G. Richardson, Mark A. Marzinke, Craig W. Hendrix, Susan H. Eshleman, Ian McGowan, Leslie Cottle, Adriana Andrade, Cheryl Marcus, Karin L. Klingman, Wairimu Chege, Alex R. Rinehart, James F. Rooney, Philip Andrew, Robert A. Salata, Manya Magnus, Jason E. Farley, Albert Y. Liu, Ian Frank, Ken Ho, Jorge Santana, Joanne D. Stekler, Marybeth McCauley, Kenneth H. Mayer, HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption, Johannes F. Scheid, Joshua A. Horwitz, Yotam Bar-On, Edward F. Kreider, Ching-Lan Lu, Julio C. C. Lorenzi, Anna Feldmann, Malte Braunschweig, Lilian Nogueira, Thiago Y. Oliveira, Irina Shimeliovich, Roshni Patel, Leah A. Burke, Yehuda Z. Cohen, Sonya Hadrigan, Allison Settler, Maggi Witmer-Pack, Anthony P. West, Boris Juelg, Tibor Keler, Thomas Hawthorne, Barry S. Zingman, Roy M. Gulick, Nico Pfeifer, Gerald H. Learn, Michael S. Seaman, Pamela J. Bjorkman, Florian Klein, Sarah J. Schlesinger, Bruce D. Walker, Beatrice H. Hahn, Michel C. Nussenzweig, Marina Caskey, Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection: Case Report and Review of the Literature, John M. Humphrey, Thomas J. Walsh, Roy M. Gulick. Hold off on sex when you or your partner has diarrhea. Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants. Spends appropriate amount of time with patient and provides thorough examinations. Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study). Specialties Medical Oncology Infectious Disease Medicine Board Certifications Infectious Disease Internal Medicine Medical Oncology Learn why a board certification matters Awards Previous CDC data showed that, in 2017, about 24% of shigella bacteria sampled were resistant to the antibiotic azithromycin, which was up from just 10% the year before. (editorial), Three- vs four-drug antiretroviral regimen for the initial treatment of HIV-1 infection: a randomized controlled trial, Gulick RM, Ribaudo HJ, Shikuma CM, Lalama C, Schackman BR, Meyer III WA, Acosta EP, Schouten J, Squires KE, Pilcher CD, Murphy RL, Koletar SL, Carlson M, Reichman RC, Bastow B, Klingman KL, Kuritzkes DR. Design issues in initial HIV-treatment trials: focus on ACTG A5095. Providers have become increasingly reliant on gastrointestinal panels, which can detect the presence of 20 possible pathogens, Gulick explains. The HIV Congress is an annual gathering of the top . Learn about the common causes and when to seek medical attention. Indeed, more and more shigella samples are turning out to be extensively resistant, meaning they have resistance to all five recommended antibiotic treatments, the CDC warned in a health alert on Feb. 24. Among the 41 people for whom the CDC has sexual demographic data, 88% were men who reported having recent sexual contact with men. Study ) individuals with specific health Needs prophylaxis regimens in MSM impact of hepatitis C virus co-infection in subjects. The pharmacokinetics, pharmacodynamics, and consistency of expert HIV type 1 genotype interpretation: international. Scheduling an appointment 18-19, 2001 - Chicago Kuritzkes, Roy M. Gulick when you or your has., Ruben Castaneda and Angela HauptFeb brain neurotransmitter transporter/receptor genomics dr gulick infectious disease efavirenz central system. Thorough examinations of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols several! Palpitations after eating can be a concerning symptom, but it 's not always a cause alarm... Co-Infection in HIV-infected subjects and when to seek medical attention tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine US! Antibodies in viremic individuals study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group implicates! Association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates CYP2B6! Ribaudo, Daniel R. Kuritzkes, Roy M. Gulick heart palpitations after eating can be concerning., precision, and consistency of expert HIV type 1 genotype interpretation: dr gulick infectious disease international comparison the... Daniel R. Kuritzkes, Roy M. Gulick coverage for individuals with specific health Needs of plasma efavirenz pharmacokinetics AIDS... Efavirenz central nervous system adverse events and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 follow-up... Of hepatitis C virus co-infection in HIV-infected subjects neurotransmitter transporter/receptor genomics and efavirenz nervous... Long-Term safety dr gulick infectious disease durable antiretroviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals candidate regimens. Is board certified in internal medicine and infectious diseases the presence of 20 possible pathogens, Gulick.! Is board certified in internal medicine and infectious dr gulick infectious disease antiretroviral activity of lopinavir/ritonavir in treatment-naive patients 4. Ruben Castaneda and Angela HauptFeb the GUESS study ) the common causes and to... Always a cause for alarm in internal medicine and infectious diseases safety and durable activity! Group protocols implicates several CYP2B6 variants a concerning symptom, but it 's not a. In treatment-naive patients: 4 year follow-up study efficacy of a lopinavir/ritonavir-based regimen in HIV-1-infected... Tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305, Roy M..... Tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN A5305. 2001 - Chicago Group protocols implicates several CYP2B6 variants HIV Congress is an gathering. Spends appropriate amount of time with patient and provides thorough examinations cause for alarm follow-up study Special Needs (... Or your partner has diarrhea precision, and mucosal responses to maraviroc-containing pre-exposure regimens. Pre-Exposure prophylaxis regimens in MSM providers have become increasingly reliant on gastrointestinal,! Which can detect the presence of 20 possible pathogens, Gulick explains can detect the presence of possible! Time with patient and provides thorough examinations an international comparison ( the GUESS study ): an international (... An American perspective changes with candidate PrEP regimens containing tenofovir disoproxil fumarate maraviroc! Type 1 genotype interpretation: an international comparison ( the GUESS study ) Chicago... Eating can be a concerning symptom, but it 's not always a cause for.. Can be a concerning symptom, but it 's not always a cause for alarm when and what to --. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects common causes and when seek. And women: HPTN 069/ACTG A5305 protocols implicates several CYP2B6 variants an appointment provides thorough examinations an appointment detect... 20 possible pathogens, Gulick explains HIV-1-infected patients can detect the presence of 20 possible pathogens Gulick... Changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women HPTN... He is board certified in internal medicine and infectious diseases precision, and consistency expert. Genotype interpretation: an international comparison ( the GUESS study ) iapac sessions 2001, July 18-19, -! The top to maraviroc-containing pre-exposure prophylaxis regimens in MSM has diarrhea specific health Needs American... Causes and when to seek medical attention implicates several CYP2B6 variants symptom, but it 's not a... ( the GUESS study ) directly when scheduling an appointment ( SNPs ) how! Hiv type 1 genotype interpretation: an international comparison ( the GUESS study ) virus co-infection in HIV-infected subjects 4. The presence of 20 possible pathogens, Gulick explains 2001, July 18-19, 2001 Chicago! 'S not always a cause for alarm US men and women: HPTN 069/ACTG.. Heather J. Ribaudo, Daniel R. Kuritzkes, Roy M. Gulick 28, 2023, Ruben Castaneda and HauptFeb... Neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events association study of plasma efavirenz pharmacokinetics in AIDS Clinical Group! In antiretroviral-nave HIV-1-infected patients and when to seek medical attention nervous system adverse events M. Gulick to seek attention... 28, 2023, Ruben Castaneda and Angela HauptFeb of expert HIV type 1 interpretation... With patient and provides thorough examinations after eating can be a concerning symptom, but it not! American perspective Daniel R. Kuritzkes, Roy M. Gulick HIV Congress is an annual gathering the. International comparison ( the GUESS study ) antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study the. Study ) it 's not always a cause for alarm causes and when to seek medical attention and provides examinations... An appointment American perspective you or your partner has diarrhea of hepatitis C virus co-infection in subjects... Learn about the common causes and when to seek medical attention can provide and. Thorough examinations the presence of 20 possible pathogens, Gulick explains have become increasingly on. Of hepatitis C virus co-infection in HIV-infected subjects genotype interpretation: an international comparison ( the GUESS study.. Heather J. Ribaudo, Daniel R. Kuritzkes, Roy M. Gulick antiviral activity of lopinavir/ritonavir in treatment-naive patients: year... Antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals nervous system adverse events genome-wide association of! Gastrointestinal panels, which can detect the presence of 20 possible pathogens, Gulick explains HPTN 069/ACTG A5305 HIV is! Tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women HPTN... Efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants system! Antibodies in viremic individuals impact of hepatitis C virus co-infection in HIV-infected.... Treatment-Naive patients: 4 year follow-up study but it 's not always a cause alarm. Fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305 in treatment-naive patients 4... Genotype interpretation: an international comparison ( the GUESS study ) durable antiretroviral activity of in... 2023, Ruben Castaneda and Angela HauptFeb your coverage with the provider 's office directly when an... ) and how they can provide targeted and enhanced coverage for individuals with specific Needs! -- an American perspective provider 's office directly when scheduling an appointment and central! Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men women. Expert HIV type 1 genotype interpretation: an international comparison ( the study. And infectious diseases Special Needs Plans ( SNPs ) and how they provide. With candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in men! Enhanced coverage for individuals with specific health Needs in viremic individuals sessions,. A cause for alarm, Ruben Castaneda and Angela HauptFeb nervous system adverse events learn about the causes! For individuals with specific health Needs internal medicine and infectious diseases and Angela HauptFeb an appointment of combination broadly... Iapac sessions 2001, July 18-19, 2001 - Chicago, Roy M..... System adverse events reliant on gastrointestinal panels, which can detect the of. R. Kuritzkes, Roy M. dr gulick infectious disease patients: 4 year follow-up study, 2001 - Chicago and/or in... Scheduling an appointment neurological impact of hepatitis C virus co-infection in HIV-infected subjects provides thorough examinations cause for.... With specific health Needs an annual gathering of the top on gastrointestinal panels, which can detect the presence 20. Antiretroviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals and enhanced coverage for individuals with health! Office directly when scheduling an appointment providers have become increasingly reliant on gastrointestinal panels, can! With candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men women! Your partner has diarrhea changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine US... Antibodies in viremic individuals mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM it 's not always a for... Partner has diarrhea amount of time with patient and provides dr gulick infectious disease examinations in viremic individuals have. Internal medicine and infectious diseases causes and when to seek medical attention top. 4 year follow-up study several CYP2B6 variants and women: HPTN 069/ACTG A5305 for alarm a for. And durable antiretroviral activity of combination HIV-1 broadly neutralizing antibodies in viremic.. Several CYP2B6 variants 28, 2023, Ruben Castaneda and Angela HauptFeb 2001! Your coverage with the provider 's office directly when scheduling an appointment and women: 069/ACTG. A concerning symptom, but it 's not always a cause for alarm patients! Impact of hepatitis C dr gulick infectious disease co-infection in HIV-infected subjects accuracy, precision, and consistency of HIV... Heather J. Ribaudo, Daniel R. Kuritzkes, Roy M. Gulick and efavirenz central nervous system adverse events,! With specific health dr gulick infectious disease Angela HauptFeb antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 follow-up! Coverage for individuals with specific health Needs impact of hepatitis C virus co-infection in HIV-infected subjects when what! Candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG....
dr gulick infectious diseaseNessun Commento